4//SEC Filing
VistaGen Therapeutics, Inc. 4
Accession 0001415889-17-000681
$VTGNCIK 0001411685operating
Filed
Apr 27, 8:00 PM ET
Accepted
Apr 28, 3:32 PM ET
Size
5.5 KB
Accession
0001415889-17-000681
Insider Transaction Report
Form 4
Smith Mark Alan
CHIEF MEDICAL OFFICER
Transactions
- Award
Stock Option (Right to Buy)
2017-04-26+125,000→ 125,000 totalExercise: $1.96Exp: 2027-04-26→ Common Stock (125,000 underlying)
Footnotes (1)
- [F1]One third (1/3rd) of the total shares shall vest one (1) year following the date of grant and 1/24th of the remaining number of shares shall vest monthly thereafter until all awarded shares are fully vested three (3) years from the date of grant.
Documents
Issuer
VistaGen Therapeutics, Inc.
CIK 0001411685
Entity typeoperating
IncorporatedNV
Related Parties
1- filerCIK 0001411685
Filing Metadata
- Form type
- 4
- Filed
- Apr 27, 8:00 PM ET
- Accepted
- Apr 28, 3:32 PM ET
- Size
- 5.5 KB